[5] Vishnevsky AS，Bokhman YaV，Loutfi G. Favourable influenceof adjuvant hormone therapy by oxyprogesterone caproate ( OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients[J]. Eur J Gynaecol Oncol ......